Introduction
Traditionally, perivascular adipose tissue (PVAT) has been regarded as an inert fat storage organ and structrual support for the vasculature. More recently, visceral adipose has been increasingly recognized as the largest endocrine organ in the body and a source of numerous anti-and proinfl ammatory mediators. 1, 2 Th e proximity of PVAT adipocytes to the adventitia and access to the vasa vasorum suggests that secretion of adipokines, cytokines, and other mediators may directly infl uence vascular infl ammation and participate in the pathogenesis of vascular stiff ness and atherosclerosis. [3] [4] [5] Despite increasing recognition of a potential role for depot-specifi c visceral adipose in the pathogenesis of cardiovascular disease, 1 links among PVAT, complement activation, vascular stiff ening, and atherosclerosis have not been explored.
We have recently demonstrated specific deposition of complement proteins C3 and C4 along the peripheral aspect of the external elastic lamina (EEL) in murine aortas of both control and ApoE(−/−) models prior to endothelial plaque development. 6 We have also demonstrated that increasing amounts of complement deposition are associated with age-related and disease-related vascular stiff ness in these mice in the absence of plaque or other evidence of atherosclerosis. 6 The current investigation was designed to determine the three-dimensional morphology and ultrastructural features of the mouse aortic wall, to identify the targets of C3 and C4 binding within vascular adventitia, and to determine if PVAT may be a source of complement proteins that participate in this pathogenic process.
with DAPI to label nuclei. Th e slides were washed with 0.5% BSA followed by a PBS wash and coverslipped with Permafl uor (Th ermo Scientifi c, Brookfi eld, WI, USA). Slides were refrigerated and imaged under a confocal microscope (Olympus, Fluoview 500, Center Valley, PA, USA) within 24 hours.
Scanning electron microscopy (SEM)
Excised aortas were perfused and placed within a 2.5% glutaraldehyde bath and refrigerated for 60 minutes for morphological preservation. The aortas were sectioned longitudinally and cross-sectionally to produce en face and transverse sections, respectively, washed in PBS, and submerged in 1% osmium oxide for 60 minutes. Th e specimens were dehydrated in a series of ethanol washes and rinsed in hexamethyldisilazane (HMDS). Th e specimens were placed onto electron microscopy (EM) stubs with conductive copper biadhesive tape, sputter coated with gold, and placed in the fi eld emission scanning electron microscope (JEOL, Tokyo, Japan) at 3 kV.
Complement C3 and C4: immuno-scanning electron microscopy (iSEM) Monoclonal C3 and C4 rat anti-mouse primary antibodies (Cedarlane Laboratories) and an isotype control IgG2a (BD Pharmingen) were used with a goat anti-rat 18-nm colloidal gold particle secondary antibody (Jackson ImmunoResearch, West Grove, PA, USA). Slides were processed in the same manner as the IF slides except that normal goat serum was used as the blocking agent and the secondary antibody was applied and refrigerated overnight. Upon completion, the slides were placed in 2.5% glutaraldehyde for 60 minutes at 4°C. The slides were dehydrated through a series of ethanol washes and processed with HMDS. The slides were placed on EM stubs with copper biadhesive tape, carbon coated, and placed in the field emission scanning electron microscope at 10 kV for back scatter imaging (BSI) and secondary electron imaging (SEI).
For iSEM analysis, two images were jointly obtained to capture both the nano-scale gold primary at an extreme magnifi cation (BSI approximately ×27,000) and a reduced macro-scale magnifi cation of the specimen (SEI approximately ×1,000) orienting the viewer to the labeling location on the specimen. For ease of identifi cation, the 15-nm and 18-nm gold label secondary antibody attachment of the BSI were colored in red using Adobe Photoshop Elements 8.0 (Seattle, WA, USA).
Results

Nonuniform PVAT distribution surrounding the murine aorta
Initial studies were performed to determine the gross and ultrastructural morphology of the PVAT and its geometry with respect to the descending aorta. Histologic and SEM images demonstrated extensive PVAT surrounding the descending aorta, in both ApoE(−/−) and control mice. Th e aorta was completely surrounded by PVAT beginning at the aortic arch. However, progressing distally, the PVAT along the descending aorta developed into a trileafl et pyramidal distribution not previously reported in mice but observed in computed tomography anatomy studies of humans 7 ( Figure 1 ). Th e PVAT appeared to be tethered to the wall of the aorta at three specifi c sites on the vascular circumference.
Age and strain-dependent complement accumulation in the vascular wall and surrounding PVAT
In previous studies, demonstrating C3 and C4 deposition along the EEL, it was not possible to determine if PVAT might be a source of the complement proteins because it had been stripped from the vessel wall during harvesting. Th erefore, in these studies we confi rmed the linear deposition of complement along the EEL and also demonstrated the presence of C3 and C4 throughout the surrounding PVAT in both control and ApoE(−/−) mouse strains at all ages. Th e high concentration of complement proteins at the EEL was maintained at young ages without deposition in the vascular wall or on the luminal surface prior to atherosclerotic lesion development within the lumen ( Figure 2 ). No substantial differences between mouse strains were noted. We also detected linear deposition of C3 and C4 surrounding the PVAT in both mouse strains at all ages ( Figure 3C ). At older ages, the ApoE(−/−) strain maintained complement deposition throughout the PVAT. With the development of atherosclerotic lesions in the lumen, the complement accumulation in the ApoE(−/−) mice then extended from the PVAT through the arterial wall and into the plaque ( Figure 3D-F ) . Control mice at 36 weeks had the same accumulation of complement throughout the PVAT, but the deposition was interrupted at the EEL with limited labeling of the media ( Figure 3A-C ) . We also noted increased cellular infi ltrates in ApoE(−/−) specimens ( Figure 3D-F ) .
Collagen Types I and III are present in the vascular wall and surrounding PVAT independent of age or strain The distinct complement patterns detected along the EEL, throughout the adventitia, and surrounding the PVAT suggested structural proteins including collagen and elastin as possible complement-binding sites. As seen in Figures 2 and 3 , the large bands of elastin fi bers autofl uoresce. Consequently, we evaluated the collagen distribution in the vascular wall and surrounding PVAT through confocal IF ( Figure 2C ). In both mouse strains, a heterogeneous mix of collagen types I and III (not shown) was identifi ed throughout the media and adventitia extending into the extracellular matrix of the surrounding PVAT. In addition, a collagen type I sheath was detected surrounding the PVAT in both mouse strains at all ages ( Figure 3C ).
Morphological identifi cation of collagen and elastin through SEM analysis
Prior to explicitly identifying the binding site(s) of complement proteins C3 and C4, we performed a rigorous characterization of the vascular wall and surrounding PVAT using SEM. In both mouse strains, regardless of age, the ECM components of the arterial wall including the thick, rolling elastin layers and the characteristic 67-nm banding pattern of collagen were well preserved and were morphologically identifi able without the need for immunohistochemistry ( Figure 4A and B ) . Th e luminal surface appeared undamaged and relatively smooth for both mouse strains in the absence of plaque, with the elastic lamina producing a rippled eff ect due to the preservation of aortic tissue in an unstressed or nonpressurized state ( Figure 4C ). The surrounding PVAT was also readily identifiable surrounding the aorta in both strains regardless of age ( Figure 4E and F ) along with the external collagen type I sheath previously detected through IF ( Figure 4E ). An interesting observation made possible through SEM characterization was the apparent vascularization of the murine PVAT. Th is suggests an underlying vasa vasorum not previously described or thought to be necessary due to the small diameter of the murine vasculature ( Figure 4F ).
Complement C3 and C4 proteins bind to collagen and elastin
Th e distinct complement-binding patterns observed through confocal IF suggested that the extracellular elastin and collagen fi bers might be specifi c targets. Given the detail inherent in the SEM images and ability to identify both collagen and elastin, we utilized iSEM to determine specifi cally the structures that complement proteins were binding.
Th e iSEM studies confi rmed the confocal IF results, demonstrating predominant binding of anti-C3 ( Figure 5 ) and anti-C4 ( Figure 6 ) monoclonal antibodies to the peripheral aspect of the EEL, throughout the adventitia, and to the surrounding PVAT at all ages regardless of strain. Th is is of note considering there is no evidence of luminal lesion development in either strain, yet there is a clear demarcation of complement at the EEL, adventitia, and PVAT at young ages.
At older ages, this same pattern was present in both strains (C3: Figure 5A -D and C4: Figure 6A -D ); however, with the onset of luminal lesion formation in the ApoE(−/−) strain, the EEL boundary was no longer a line of demarcation and the accumulation of complement extended into the media, the internal elastic lamina, and atherosclerotic lesions (C3: Figure 5A and B and C4: Figure 6A and B ). Th e presence of C3 and C4 within the aorta of the control strain was consistently maintained within the EEL boundary (C3: Figure 5C and D and C4: Figure 6C and D ).
Discussion
Th is is the fi rst study to rigorously characterize the three-dimensional morphology and ultrastructure of the mouse aorta. The most important advance of these eff orts is our capacity to demonstrate the binding of C3-and C4-derived ligands to collagen and elastin fibers within the adventitia of the vascular wall. We also present evidence suggesting that perivascular adipose serves as the source of these complement proteins. Together, these observations support an "outside-in" model of vascular stiff ness and atherosclerosis. 8 High circulating levels of C3 and C4 have been correlated with increased rates of myocardial infarction in both healthy women and those with established coronary artery disease. 9, 10 Traditional models have suggested this systemic source of complement as a participant in the infl ammatory responses that occur during development of luminal atherosclerotic lesions. [11] [12] [13] [14] Th is model can be referred to as the "inside-out" theory of vascular pathogenesis. However, our previous studies had suggested an alternative role for complement proteins during progression of vascular stiff ness and atherosclerosis. 6 In those studies, we had identifi ed colocalization of C3 and C4 with collagen and elastin fi bers in the adventitia not only during atherosclerosis but also during normal aging in the absence of plaque or other evidence of infl ammation. In the current studies, we expanded these observations to examine the ultrastructural proximity of C3 and C4 to elastin and collagen and to identify a potential source of these proteins that were apparently targeted to the adventitial structures. Th e results demonstrate specifi c binding of C3-and C4-derived ligands to elastin and collagen fi bers and not to other components of the adventitia.
There are several plausible mechanisms that may be responsible for binding of complement proteins to collagen and elastin. Complement receptors are cell specifi c, ruling out a receptor-ligand interaction. Th erefore, one particularly attractive mechanism would be covalent attachment of C3-and C4-derived ligands via the unique thiolester bonds present within these molecules that are capable of forming ester or amide linkages aft er recognizing free hydroxyl or amino groups, respectively. 15 In the absence of complement regulatory proteins on elastin or collagen fi bers, hydrolysis of C3 and/or C4 within the adventitia could readily lead to the patterns of deposition observed in the current study. Such direct binding of C3-and C4-derived ligands to collagen and elastin might contribute to, or be a primary determinant of, increased vascular stiff ness. Th is complement deposition may also stimulate or contribute to atherosclerosis.
In addition to, or as an alternative to, direct covalent attachment, C3-and C4-derived molecules may bind indirectly to elastin and collagen. For example, fi bromodulin, lumican, and decorin are members of the leucine-rich repeat glycoprotein/ proteoglycan family, which bind to the types of collagen found in the vascular wall. [16] [17] [18] Fibromodulin been found to bind C1q and activate the classical pathway, and has been identified throughout the aortic wall and atherosclerotic lesions. 19 Another participant in this mechanistic process might be adiponectin, which is produced by adipocytes, binds to the collagens of the vascular wall, and initiates complement activation. 20, 21 In our previous studies, we had identifi ed colocalization of C3 and C4 within elastin and collagen in the adventitia 6 , however the potential source of these proteins was not apparent, and the possible role of PVAT could not be determined, because it had been stripped from the aorta during harvest of the specimen. In these studies, the PVAT was preserved, allowing us to demonstrate the presence of C3 and C4 in a cytoplasmic pattern within adipose, suggesting the capacity of adipocytes to produce C3 and C4, which may then be targeted to the elastin and collagen within the adventitia under appropriate conditions. PVAT is in unique proximity to the external layers of the vascular wall. Previous studies have suggested a potential link between adipose and complement activation. 22 Several studies demonstrate that adipose infl ammation is directly linked to the alternative pathway through the adipocyte production of adipsin (adipocyte-derived human factor D) , 23, 24 factor B, and C3, 25 and in vivo data suggest adipose tissue activates complement in normal mice. 24 Dysfunction of the classical pathway has also been associated with murine models of obesity and insulin resistance through abnormal in vivo adipocyte and immune cell production of C1 complex proteins (C1q, C1r, C1s). 26 Most recently, a direct influence of adipose-derived complement on the vasculature was demonstrated by a report showing that PVAT-dervied C3 stimulated adventitial fi broblast migration and diff erentiation via the c-Jun N-terminal kinase pathway in a rat model of hypertension. One unanswered question is the mechanism by which C3 and C4 and their derived ligands penetrate the EEL. During repair of vascular injury (i.e., atheroma) or remodeling of the vascular wall due to nonnormal stresses (i.e., hypertension), various mechanisms infl uence the integrity of the vascular wall including pro-and antiinflammatory production of chemokines, cytokines, and more recently noted adipokines that facilitate cellular migration through the vascular wall and increase vascular permeability. In addition, sustained vascular dysfunction can physically tear and degrade the vessel wall structural components including elastin and collagen, which triggers an additional infl ammatory response to repair the injury. [28] [29] [30] Th is degradation of elastin and increased permeability of the vascular wall may facilitate complement deposition from both the PVAT as well as from the circulation, thus producing an infl ammatory feedback loop. 
Conclusion
Although complement activation is known to occur within atherosclerotic plaque and luminal lesions, we have demonstrated that the complement system may also independently target the adventitia during progression of vascular stiffness and atherosclerosis. C3-and C4-derived ligands, generated from native proteins produced in the PVAT, may bind directly or indirectly to elastin and collagen fi bers and contribute to an "outside-in" mechanism of vascular pathogenesis.
